Abstract:Th9 cells, a subset of T-helper cells producing interleukin-9 (IL-9), play a vital role in the adaptive immune response and have diverse effects in different diseases. Regulated by transcription factors like PU.1 and IRF4, and cytokines such as IL-4 and TGF-β, Th9 cells drive tissue inflammation. This review focuses on their emerging role in immunopathophysiology. Th9 cells exhibit immune-mediated cancer cell destruction, showing promise in glioma and cervical cancer treatment. However, their role in breast and lung cancer is intricate, requiring a deeper understanding of pro- and anti-tumor aspects. Th9 cells, along with IL-9, foster T cell and immune cell proliferation, contributing to autoimmune disorders. They are implicated in psoriasis, atopic dermatitis, and infections. In allergic reactions and asthma, Th9 cells fuel pro-inflammatory responses. Targeting Foxo1 may regulate innate and adaptive immune responses, alleviating disease symptoms. This comprehensive review outlines Th9 cells' evolving immunopathophysiological role, emphasizing the necessity for further research to grasp their effects and potential therapeutic applications across diseases. The immune system relies on CD4 + T cells, specifically Th9 cells, which produce Interleukin-9 (IL-9) to combat infections. Th9 cells have distinct functions regulated by various factors and are implicated in diseases, including cancer. Preclinical studies suggest Th9 cells could target tumors, but their role in cancer remains intricate. In lung and breast cancer, Th9 cells influence tumor growth and immune responses. Glioma research explores inducing Th9 cells to inhibit brain tumor growth. Th9 cells exhibit both positive and negative associations with colorectal cancer, lymphoma, and melanoma. Investigation into Th9 cells extends to autoimmune diseases like Graves' disease, inflammatory bowel disease, psoriasis, lupus, scleroderma, rheumatoid arthritis, and multiple sclerosis, where they may contribute to inflammation. In atopic dermatitis, elevated IL-9 levels correlate with disease severity, indicating Th9 cells' involvement in inflammation and cell activation. The complexity of Th9 cells underscores the necessity for disease-specific therapies. Understanding Th9 cells and IL-9 is pivotal for developing targeted treatments, emphasizing the nuanced role these cells play in diverse diseases and the potential for tailored therapeutic approaches.

CD96 expression determines the inflammatory potential of IL-9–producing Th9 cells

TL1A Modulates the Severity of Colitis by Promoting Th9 Differentiation and IL-9 Secretion.

CD96 Downregulation Promotes the Immune Response of CD4 T Cells and Associates with Ankylosing Spondylitis.

IL-9 and Th9 cells in health and diseases—From tolerance to immunopathology

IL-9 and its receptor are predominantly involved in the pathogenesis of UC

IL-1β promotes IL-9-producing Th cell differentiation in IL-2-limiting conditions through the inhibition of BCL6

Th9 Cells: Probable players in ulcerative colitis pathogenesis

Antigen-Specific Th9 Cells Exhibit Uniqueness in Their Kinetics of Cytokine Production and Short Retention at the Inflammatory Site

Targeting T-helper 9 Cells and Interleukin-9 in Autoimmune Diseases.

A Decade of Th9 Cells: Role of Th9 Cells in Inflammatory Bowel Disease

Th9 cells and IL-9 in autoimmune disorders: Pathogenesis and therapeutic potentials

The emerging role of T helper 9 (Th9) cells in immunopathophysiology: A comprehensive review of their effects and responsiveness in various disease states

TNF superfamily cytokines in the promotion of Th9 differentiation and immunopathology

PU.1-driven Th9 Cells Promote Colorectal Cancer in Experimental Colitis Models Through Il-6 Effects in Intestinal Epithelial Cells

Differentiation, Regulation and Function of Th9 Cells

Activin A Promotes Differentiation of a Pathogenic Multicytokine IL-9-secreting CD4+ T Cell Population

CD5L/AIM Regulates Lipid Biosynthesis and Restrains Th17 Cell Pathogenicity

The symphony of the ninth: the development and function of Th9 cells

Th9 cell development requires a BATF-regulated transcriptional network

Th9 Cells in Allergic Disease

Th9 Cells Are Subjected to PD-1/PD-L1-mediated Inhibition and Are Capable of Promoting CD8 T Cell Expansion Through IL-9R in Colorectal Cancer.